Agilent Technologies, Inc. (NYSE:A) Shares Sold by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. lessened its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 19.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 62,825 shares of the medical research company’s stock after selling 14,693 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Agilent Technologies were worth $88,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in A. Private Advisor Group LLC lifted its position in Agilent Technologies by 4.2% in the third quarter. Private Advisor Group LLC now owns 13,137 shares of the medical research company’s stock valued at $1,469,000 after acquiring an additional 532 shares during the last quarter. Nomura Asset Management Co. Ltd. boosted its position in shares of Agilent Technologies by 0.6% in the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 75,994 shares of the medical research company’s stock valued at $8,498,000 after purchasing an additional 469 shares during the period. Corient Private Wealth LLC boosted its position in shares of Agilent Technologies by 0.7% in the 3rd quarter. Corient Private Wealth LLC now owns 167,335 shares of the medical research company’s stock valued at $18,711,000 after purchasing an additional 1,231 shares during the period. Syon Capital LLC acquired a new position in Agilent Technologies during the third quarter worth approximately $213,000. Finally, NBC Securities Inc. acquired a new position in Agilent Technologies during the third quarter worth approximately $287,000.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on A. Oppenheimer raised their target price on shares of Agilent Technologies from $67.00 to $90.00 and gave the stock an “outperform” rating in a research report on Tuesday, March 26th. Evercore ISI lifted their price objective on shares of Agilent Technologies from $132.00 to $145.00 and gave the company an “in-line” rating in a research note on Thursday, April 4th. Citigroup increased their target price on shares of Agilent Technologies from $130.00 to $145.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 28th. Stifel Nicolaus upgraded Agilent Technologies from a “hold” rating to a “buy” rating and boosted their price target for the company from $145.00 to $163.00 in a research report on Friday, April 5th. Finally, Barclays increased their price objective on Agilent Technologies from $125.00 to $135.00 and gave the stock an “underweight” rating in a research report on Wednesday, April 10th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $141.06.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, SVP Philip Binns sold 2,827 shares of the company’s stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $147.54, for a total value of $417,095.58. Following the sale, the senior vice president now owns 9,997 shares of the company’s stock, valued at $1,474,957.38. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Agilent Technologies news, SVP Philip Binns sold 2,827 shares of the firm’s stock in a transaction on Monday, March 25th. The stock was sold at an average price of $147.54, for a total transaction of $417,095.58. Following the completion of the transaction, the senior vice president now owns 9,997 shares of the company’s stock, valued at $1,474,957.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Heidi Fields sold 1,658 shares of the company’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $144.34, for a total value of $239,315.72. Following the completion of the sale, the director now owns 54,976 shares in the company, valued at $7,935,235.84. The disclosure for this sale can be found here. Insiders sold 61,610 shares of company stock valued at $9,220,333 in the last 90 days.

Agilent Technologies Stock Performance

Shares of A opened at $150.66 on Friday. The company has a market capitalization of $44.15 billion, a PE ratio of 35.87, a P/E/G ratio of 4.04 and a beta of 1.13. Agilent Technologies, Inc. has a 52-week low of $96.80 and a 52-week high of $155.35. The company has a 50-day simple moving average of $144.06 and a 200-day simple moving average of $136.19. The company has a quick ratio of 2.04, a current ratio of 2.68 and a debt-to-equity ratio of 0.41.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Tuesday, February 27th. The medical research company reported $1.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.07. The company had revenue of $1.66 billion during the quarter, compared to the consensus estimate of $1.59 billion. Agilent Technologies had a net margin of 18.35% and a return on equity of 27.09%. The company’s revenue for the quarter was down 5.5% on a year-over-year basis. During the same period last year, the firm earned $1.37 EPS. Equities research analysts predict that Agilent Technologies, Inc. will post 5.5 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 24th. Shareholders of record on Tuesday, July 2nd will be issued a $0.236 dividend. This represents a $0.94 annualized dividend and a yield of 0.63%. The ex-dividend date is Tuesday, July 2nd. Agilent Technologies’s dividend payout ratio (DPR) is 22.38%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.